SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 65 filers reported holding SUTRO BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $55,500 | +6.5% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $52,100 | -30.3% | 10,000 | +9.9% | 0.00% | -33.3% |
| Q1 2022 | $74,802 | -37.4% | 9,100 | +13.4% | 0.00% | -25.0% |
| Q4 2021 | $119,412 | -21.2% | 8,025 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $151,592 | +1.6% | 8,025 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $149,185 | -14.3% | 8,025 | +4.9% | 0.01% | -25.0% |
| Q1 2021 | $174,114 | +8.4% | 7,650 | +3.4% | 0.01% | 0.0% |
| Q4 2020 | $160,654 | +88.6% | 7,400 | -12.7% | 0.01% | +60.0% |
| Q3 2020 | $85,174 | +83.7% | 8,475 | +41.8% | 0.01% | +66.7% |
| Q2 2020 | $46,366 | +30.8% | 5,975 | +71.9% | 0.00% | 0.0% |
| Q1 2020 | $35,445 | +48.2% | 3,475 | +59.8% | 0.00% | +50.0% |
| Q4 2019 | $23,925 | +338.7% | 2,175 | +262.5% | 0.00% | – |
| Q3 2019 | $5,454 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $33,918,000 | 14.78% |
| Samsara BioCapital, LLC | 1,675,579 | $31,149,000 | 3.84% |
| First Light Asset Management, LLC | 2,072,875 | $38,535,000 | 2.31% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,253,000 | 1.88% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $18,616,000 | 1.72% |
| Opaleye Management Inc. | 496,900 | $9,237,000 | 1.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,590,000 | 0.68% |
| Parkman Healthcare Partners LLC | 163,389 | $3,037,000 | 0.66% |
| Eventide Asset Management | 2,370,975 | $44,076,000 | 0.59% |
| BVF INC/IL | 826,825 | $15,371,000 | 0.58% |